Quality of life in patients with multiple sclerosis

Background: Quality of life assessment in patients with Multiple sclerosis (MS) is invaluable for a proper evaluation of disease severity, appropriate choice of therapy and monitoring of its effects. The aim of this study was to assess the quality of life of patients with MS and to identify gender d...

Full description

Bibliographic Details
Main Authors: Ilić Darko, Stefanović Srđan, Janković Slobodan
Format: Article
Language:English
Published: Medicinsko društvo za racionalnu terapiju Republike Srbije 2011-01-01
Series:Racionalna Terapija
Subjects:
Online Access:http://scindeks-clanci.ceon.rs/data/pdf/1821-0538/2011/1821-05381102001I.pdf
id doaj-0f00cc26f6c947c6a70744d92bff204d
record_format Article
spelling doaj-0f00cc26f6c947c6a70744d92bff204d2020-11-24T22:41:48ZengMedicinsko društvo za racionalnu terapiju Republike SrbijeRacionalna Terapija1821-05382217-86272011-01-01321610.5937/racter1102001I1821-05381102001IQuality of life in patients with multiple sclerosisIlić Darko0Stefanović Srđan1Janković Slobodan2University of Kragujevac, Faculty of Medicine, Kragujevac, SerbiaUniversity of Kragujevac, Faculty of Medicine, Kragujevac, SerbiaMedicinski fakultet, Katedra za farmakologiju i toksikologiju, KragujevacBackground: Quality of life assessment in patients with Multiple sclerosis (MS) is invaluable for a proper evaluation of disease severity, appropriate choice of therapy and monitoring of its effects. The aim of this study was to assess the quality of life of patients with MS and to identify gender differences in examined outcome. Patients and Methods: A descriptive cross-sectional study was conducted from August 2010 to May 2011. The data were obtained by anonymous survey of 110 patients. Quality of life of the patients was measured by the instrument 'The World Health Organization Quality of Life (WHOQOL) - BREF'. Data on gender and age of patients, type of MS, the number of relapses during the last 2 years, current therapy, dose regimens of certain drugs, and the amount of money the patients spend each month for the purchase of drugs that are not issued at the expense of health insurance fund, were obtained using a distinct structured questionnaire. The collected data were analyzed using simple descriptive statistics and Student's t-test for independent samples. Results: Of the total 110 interviewed patients, 70% (n = 77) were female and 30% (n = 33) male. There were no significant gender differences in the disease duration, number of relapses in the last two years and spending of more than 1000 RSD per month for purchase of drugs that were not issued at the expense of the health insurance fund. Significantly better quality of life was recorded in women than men (p = 0.031), mainly on account of differences in the assessment of the domain of 'Environment' (p = 0.025), as measured by WHOQOL-BREF scale. Conclusion: This study has shown that females tolerate difficulties caused by multiple sclerosis better than men, and also have a better quality of life than men with the same clinical form of the disease and identical symptoms, treated with the same therapy. .http://scindeks-clanci.ceon.rs/data/pdf/1821-0538/2011/1821-05381102001I.pdfmultiple sclerosisquality of liferecurrenceWHOQOL - BREF
collection DOAJ
language English
format Article
sources DOAJ
author Ilić Darko
Stefanović Srđan
Janković Slobodan
spellingShingle Ilić Darko
Stefanović Srđan
Janković Slobodan
Quality of life in patients with multiple sclerosis
Racionalna Terapija
multiple sclerosis
quality of life
recurrence
WHOQOL - BREF
author_facet Ilić Darko
Stefanović Srđan
Janković Slobodan
author_sort Ilić Darko
title Quality of life in patients with multiple sclerosis
title_short Quality of life in patients with multiple sclerosis
title_full Quality of life in patients with multiple sclerosis
title_fullStr Quality of life in patients with multiple sclerosis
title_full_unstemmed Quality of life in patients with multiple sclerosis
title_sort quality of life in patients with multiple sclerosis
publisher Medicinsko društvo za racionalnu terapiju Republike Srbije
series Racionalna Terapija
issn 1821-0538
2217-8627
publishDate 2011-01-01
description Background: Quality of life assessment in patients with Multiple sclerosis (MS) is invaluable for a proper evaluation of disease severity, appropriate choice of therapy and monitoring of its effects. The aim of this study was to assess the quality of life of patients with MS and to identify gender differences in examined outcome. Patients and Methods: A descriptive cross-sectional study was conducted from August 2010 to May 2011. The data were obtained by anonymous survey of 110 patients. Quality of life of the patients was measured by the instrument 'The World Health Organization Quality of Life (WHOQOL) - BREF'. Data on gender and age of patients, type of MS, the number of relapses during the last 2 years, current therapy, dose regimens of certain drugs, and the amount of money the patients spend each month for the purchase of drugs that are not issued at the expense of health insurance fund, were obtained using a distinct structured questionnaire. The collected data were analyzed using simple descriptive statistics and Student's t-test for independent samples. Results: Of the total 110 interviewed patients, 70% (n = 77) were female and 30% (n = 33) male. There were no significant gender differences in the disease duration, number of relapses in the last two years and spending of more than 1000 RSD per month for purchase of drugs that were not issued at the expense of the health insurance fund. Significantly better quality of life was recorded in women than men (p = 0.031), mainly on account of differences in the assessment of the domain of 'Environment' (p = 0.025), as measured by WHOQOL-BREF scale. Conclusion: This study has shown that females tolerate difficulties caused by multiple sclerosis better than men, and also have a better quality of life than men with the same clinical form of the disease and identical symptoms, treated with the same therapy. .
topic multiple sclerosis
quality of life
recurrence
WHOQOL - BREF
url http://scindeks-clanci.ceon.rs/data/pdf/1821-0538/2011/1821-05381102001I.pdf
work_keys_str_mv AT ilicdarko qualityoflifeinpatientswithmultiplesclerosis
AT stefanovicsrđan qualityoflifeinpatientswithmultiplesclerosis
AT jankovicslobodan qualityoflifeinpatientswithmultiplesclerosis
_version_ 1725700769916649472